Vanessa Pimenta Rocha

Vanessa Pimenta Rocha

Auto-generated profile, based on publicly available information

Vanessa Pimenta Rocha

Department of Biochemistry, Biomedical Institute, UNIRIO, 20211-040, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
VRVanessa P. Rocha
Vanessa P. Rocha
SCSamir P. C. Campos
Samir P. C. Campos
CBCaroline Augusto Barros
Caroline Augusto Barros
PTPablo Trindade
Pablo Trindade
LSLeticia R. Q. Souza
Leticia R. Q. Souza
RGRafael Braga Gonçalves
Rafael Braga Gonçalves
Bovine lactoferrin (bLf) is a multifunctional protein widely associated with anticancer activity. Prostate cancer is the second most frequent type of cancer worldwide. This study was aimed at evaluating the influence of bLf on cell viability, cell cycle progression, reactive oxygen species (ROS) production, and rate of apoptosis in the human prostate cancer cell line (DU‐145). MTT assay and trypan blue exclusion were used to analyze cell viability. Morphological changes were analyzed through optical microscopy after 24 h and 48 h of bLf treatment. FITC‐bLf internalization and cellular damage were observed within 24 h by confocal fluorescence microscopy. Cell cycle analyses were performed by flow cytometry and propidium iodide. For caspases 3/7 activation and reactive oxygen species production evaluation, cells were live‐imaged using the high‐throughput system Operetta. The cell viability assays demonstrated that bLf induces cell death and morphological changes after 24 h and 48 h of treatment compared to control on DU‐145 cells. The bLf internalization was detected in DU‐145 cells, G1‐phase arrest of the cell cycle, caspase 3/7 activation, and increased oxidative stress on bLf‐treated cells. Our data support that bLf has an important anticancer activity, thus offering new perspectives in preventing and treating prostate cancer.

13 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
Carlos A. M. CarvalhoCarlos A. M. Carvalho
Carlos A. M. Carvalho
AMAline da Rocha Matos
Aline da Rocha Matos
BCBraulia Costa Caetano
Braulia Costa Caetano
ISIvanildo Sousa
Ivanildo Sousa
SCSamir Pereira da Costa Campos
Samir Pereira da Costa Campos
RGRafael Braga Gonçalves
Rafael Braga Gonçalves
Since its emergence in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been posing a serious threat to public health worldwide as the causative agent of coronavirus disease 2019 (COVID-19). Now distributed in a pandemic pattern, this disease still lacks an effective drug treatment with low toxicity, leading pharmaceutical companies and research labs to work against time to find a candidate molecule to efficiently treat the affected patients. Due to the well-known broad-spectrum antimicrobial activity of the lactoferrin protein, we sought to verify whether its bovine form (bLf) would also be effective in vitro against SARS-CoV-2. Using an antiviral assay based on quantitative reverse transcription-polymerase chain reaction (qRT-PCR), we found that bLf reduced progeny virus yield by up to ∼84,6% in African green monkey kidney epithelial cells (Vero E6) and ∼68,6% in adenocarcinomic human alveolar basal epithelial cells (A549) at 1 mg/mL, a concentration previously shown to have low cytotoxicity. Therefore, our preliminary data suggest that bLf has the potential to constitute a biochemical approach to fight the new coronavirus pandemic.